The trade-off between cold resistance and growth determines the <Emphasis Type="Italic">Nothofagus pumilio</Emphasis> treeline

The upper and poleward limit of tree distribution are usually determined by abiotic factors such as low temperature and strong winds. Thus, cold resistance is a key element for survival in high altitudes and latitudes where conditions can reduce plant growth. A trade-off between resource allocation to cold resistance and growth could emerge in populations frequently exposed to low temperatures like those in the treeline zone. We studied annual height growth and ice nucleation temperature in Nothofagus pumilio (Nothofagaceae) populations growing in its extremes of altitudinal distribution and in 3 sites situated on a latitudinal gradient in the Chilean Andes. Additionally, gas exchange, water and nitrogen use efficiency and total soluble sugar (TSS) were also measured as possible mechanisms for survival in high altitudes. Individuals from the treeline populations showed lower annual height growth and lower ice nucleation temperatures compared with those from lower populations. In the same way, individuals from more poleward populations showed lower annual height growth and lower ice nucleation temperatures. Gas exchange, water and nitrogen use efficiency and TSS were also higher in the high altitude populations. The results obtained support the hypothesis of trade-off, because the upper and poleward populations showed more cold resistance but a lower height growth. Additionally, we show that cold resistance mechanisms do not impact the physiological performance, suggesting possible adaptation of the high altitude populations. Low temperatures may be affecting cellular growth instead of photosynthesis, creating a pool of carbohydrates that could participate in cold tolerance. Other abiotic and biotic factors should be also assessed to fully understand the distributional range of Nothofagus species.     

Advances in tissue and organ replacement

Applications of regenerative medicine technology may offer new therapies for patients with injuries, end-stage organ failure, or other clinical problems. Currently, patients suffering from diseased and injured organs can be treated with transplanted organs. However, there is a shortage of donor organs that is worsening yearly as the population ages and new cases of organ failure increase. Scientists in the field of regenerative medicine and tissue engineering are now applying the principles of cell transplantation, material science, and bioengineering to construct biological substitutes that will restore and maintain normal function in diseased and injured tissues. The stem cell field is a rapidly advancing aspect of regenerative medicine as well, and new discoveries here create new options for this type of therapy. For example, therapeutic cloning, in which the nucleus from a donor cell is transferred into an enucleated oocyte in order to extract pluripotent embryonic stem cells from the resultant embryo, provides another source of cells for cell-based tissue engineering applications. While stem cells are still in the research phase, some therapies arising from tissue engineering endeavors have already entered the clinical setting, indicating that regenerative medicine holds promise for the future.     

Stem cells: cross-talk and developmental programs

The thesis advanced in this essay is that stem cells-particularly those in the nervous system-are components in a series of inborn 'programs' that not only ensure normal development, but persist throughout life so as to maintain homeostasis in the face of perturbations-both small and great. These programs encode what has come to be called 'plasticity'. The stem cell is one of the repositories of this plasticity. This review examines the evidence that interaction between the neural stem cell (as a prototypical somatic stem cell) and the developing or injured brain is a dynamic, complex, ongoing reciprocal set of interactions where both entities are constantly in flux. We suggest that this interaction can be viewed almost from a 'systems biology' vantage point. We further advance the notion that clones of exogenous stem cells in transplantation paradigms may not only be viewed for their therapeutic potential, but also as biological tools for 'interrogating' the normal or abnormal central nervous system environment, indicating what salient cues (among the many present) are actually guiding the expression of these 'programs'; in other words, using the stem cell as a 'reporter cell'. Based on this type of analysis, we suggest some of the relevant molecular pathways responsible for this 'cross-talk' which, in turn, lead to proliferation, migration, cell genesis, trophic support, protection, guidance, detoxification, rescue, etc. This type of developmental insight, we propose, is required for the development of therapeutic strategies for neurodegenerative disease and other nervous system afflictions in humans. Understanding the relevant molecular pathways of stem cell repair phenotype should be a priority, in our view, for the entire stem cell field.